Akèy › Limfom › New York › Buffalo

Etid klinik pou Limfom nan Buffalo, NY

6 etid pou Limfom ap chèche patisipan nan sit nan ak bò kote Buffalo (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Ap rekriteFaz 2

Roswell Park Comprehensive Cancer Center, Buffalo

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07015242

Collection of Tissue Samples for Cancer Research

Ap rekriteEtid obsèvasyon

Roswell Park Cancer Institute, Buffalo

2 Months · Tout sèks · Mizajou Sep 16, 2026 · NCT00900198

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Ap rekriteFaz 1/2

Roswell Park Cancer Institute, Buffalo

12 Months – 21 Years · Tout sèks · Mizajou Sep 11, 2026 · NCT04870944

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Ap rekriteFaz 1/2

Roswell Park Comprehensive Cancer Center, Buffalo

Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Ap rekriteFaz 3

Roswell Park Comprehensive Cancer Center, Buffalo

Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07188558

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Ap rekriteFaz 1/2

Roswell Park Comprehensive Cancer Center, Buffalo

Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078

Etid Limfom nan lòt vil

Lòt etid nan Buffalo

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.